PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18490434-6 2008 Rifampin increased ERBTs in CYP3A5(*)1 carriers (4.68 versus 2.60%, P = 0.0008) and noncarriers (3.55 versus 2.11%, P = 0.0017), whereas dexamethasone increased ERBTs only in CYP3A5(*)1 noncarriers (3.03 versus 2.14%, P = 0.031). Rifampin 0-8 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 28-34 30170758-3 2018 Rifampin induces UGT1A9, UGT2B7, CYP3A4, and CYP3A5. Rifampin 0-8 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 45-51 20818746-7 2010 Upon activation of PXR by rifampicin, the messenger RNA levels of CYP3A4, CYP3A5, and CYP3A7 increased 49- to 213-fold versus HepG2 cells. Rifampin 26-36 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 74-80 18490434-6 2008 Rifampin increased ERBTs in CYP3A5(*)1 carriers (4.68 versus 2.60%, P = 0.0008) and noncarriers (3.55 versus 2.11%, P = 0.0017), whereas dexamethasone increased ERBTs only in CYP3A5(*)1 noncarriers (3.03 versus 2.14%, P = 0.031). Rifampin 0-8 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 175-181 12673034-3 2003 In this study, we demonstrated the inductive effects of phenobarbital, rifampicin, carbamazepine, phenytoin, prednisolone, ciclosporin and clotrimazole on CYP3A4, CYP3A5 and CYP3A7 mRNA expression, and established the relationship between the expression of human glucocorticoid receptor alpha (hGR) mRNA and the induction of CYP3A4 mRNA in cultured HepG2 cells by reverse transcription polymerase chain reaction (RT-PCR). Rifampin 71-81 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 163-169 17978482-8 2007 On the other hand, CYP3A4, CYP3A5, and CYP3A7 mRNA expression levels in HepG2 cells were increased from 2- to 3-fold by treatment with DEX and RIF. Rifampin 143-146 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 27-33 15681896-5 2004 CYP3A4 and CYP3A5 mRNA levels after exposure to 50 microM rifampicin (positive control for CYP3As) were significantly increased by 5.8 (p<0.01) and 2.0 times (p<0.01), respectively, compared with untreated controls. Rifampin 58-68 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 11-17 15309450-6 2004 In addition, carotenoid- or retinol-mediated gene expression of PXR-responsive genes like CYP3A4/CYP3A7, CYP3A5, MDR-1 and MRP-2 has been determined in HepG2 cells by RT-PCR with up-regulative properties of beta-carotene or retinol being comparable to or even higher than that of rifampicin. Rifampin 280-290 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 105-111 15252010-3 2004 We report the induction of CYP3A5 mRNA in 13 of 16 hepatocyte preparations exposed to rifampin. Rifampin 86-94 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 27-33 15319341-8 2004 Real-time polymerase chain reaction and Western blot analysis revealed significantly increased CYP3A4 mRNA and protein levels in hepatocytes treated with 10 microM rifampicin compared with untreated cells, but only modest effects of rifampicin on CYP3A5 induction. Rifampin 164-174 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 247-253 12843640-11 2003 Exposure to rifampicin also reduced CYP3A5 and CYP3A7 mRNA levels for donors 1 and 3 at 0.5% and 2.5% DMSO. Rifampin 12-22 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 36-42 12673034-7 2003 Treatment with phenytoin, rifampicin, carbamazepine and ciclosporin induced approximately 2-fold increases in the expression of CYP3A5 mRNA, although prednisolone, phenytoin and clotrimazole had no effect. Rifampin 26-36 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 128-134 12504802-6 2003 Up-regulation of endogenous CYP3A4 and CYP3A5 mRNA was obtained by gamma-tocotrienol, the most potent activator of PXR, with the same efficacy as with rifampicin. Rifampin 151-161 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 39-45 9157990-7 1997 In one human hepatocyte culture that contained the polymorphically expressed CYP3A5 in addition to the more widely expressed CYP3A4, only CYP3A4 was induced by cyclophosphamide, ifosfamide, and rifampin. Rifampin 194-202 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 77-83 12040753-6 2002 The levels of CYP1A1, CYP2B6, CYP2C8, CYP3A4, CYP3A5, ADH3, and ABCG1 mRNA in human hepatocytes increased after exposure to rifampicin. Rifampin 124-134 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 46-52 11744607-11 2002 The mRNA of CYP2E1, CYP3A5, CYP3A7, CYP4A11, and CYP4B1 genes were variably expressed at baseline and following rifampin treatment. Rifampin 112-120 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 20-26 33963620-2 2021 Isavuconazole is metabolized by CYP3A4 and CYP3A5 and it has been shown that the CYP3A inducer rifampin reduces isavuconazole exposure. Rifampin 95-103 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 43-49